Ledger.Open graph →
SEC Form D · filed October 30, 2014

NantBioscience, Inc

Offering
$100.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CULVER CITY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Patrick Soon-Shiong · Culver City, CADirectorGerrit Klaerner · South San Francisco, CADirectorPhilip N. Sanderson · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗